{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:57:50Z","timestamp":1790639870876,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003185","name":"Fraunhofer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003495","name":"Hessian Ministry of Science and Research Arts and Culture","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003495","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.molmet.2026.102426","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T06:27:23Z","timestamp":1784615243000},"page":"102426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Sex-specific differences of amlexanox in a mouse model for atherosclerosis and MASLD"],"prefix":"10.1016","volume":"111","author":[{"given":"Eleonora","family":"Mungo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Ha\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Benning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Kuntschar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie P.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Hahnefeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Dorochow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urs","family":"Christen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Hintermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekka","family":"Medert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Freichel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Geisslinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3909-5751","authenticated-orcid":false,"given":"Ellen","family":"Niederberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.molmet.2026.102426_bib1","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1038\/s41591-024-03165-6","article-title":"Western diets and chronic diseases","volume":"30","author":"Adolph","year":"2024","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.molmet.2026.102426_bib2","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1161\/CIR.0000000000001123","article-title":"Heart disease and stroke Statistics-2023 update: a report from the American heart association","volume":"147","author":"Tsao","year":"2023","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.molmet.2026.102426_bib3","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.molmet.2026.102426_bib4","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/s12350-019-01736-6","article-title":"Non-alcoholic fatty liver disease with reduced myocardial FDG uptake is associated with coronary atherosclerosis","volume":"28","author":"Tang","year":"2021","journal-title":"J Nucl Cardiol"},{"issue":"9","key":"10.1016\/j.molmet.2026.102426_bib5","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","article-title":"NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.molmet.2026.102426_bib6","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/obr.12820","article-title":"Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome","volume":"20","author":"Lim","year":"2019","journal-title":"Obes Rev"},{"issue":"6","key":"10.1016\/j.molmet.2026.102426_bib7","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1161\/ATV.0000000000000153","article-title":"Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American heart Association","volume":"42","author":"Duell","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"10.1016\/j.molmet.2026.102426_bib8","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.tem.2019.08.008","article-title":"NAFLD and atherosclerosis: two sides of the same dysmetabolic coin?","volume":"30","author":"Stols-Goncalves","year":"2019","journal-title":"Trends Endocrinol Metabol"},{"issue":"2","key":"10.1016\/j.molmet.2026.102426_bib9","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2017.09.021","article-title":"Hypertension, diabetes, atherosclerosis and NASH: cause or consequence?","volume":"68","author":"Lonardo","year":"2018","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.molmet.2026.102426_bib10","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/gut.2003.027086","article-title":"Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance","volume":"53","author":"Donati","year":"2004","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.molmet.2026.102426_bib11","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.cgh.2021.07.039","article-title":"Hepatic fat reduction due to resmetirom in patients with nonalcoholic steatohepatitis is associated with improvement of quality of life","volume":"20","author":"Younossi","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.molmet.2026.102426_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.71613","article-title":"Beyond the green light: evaluating the uncertainties of resmetirom for non-cirrhotic nonalcoholic steatohepatitis treatment","volume":"9","author":"Sajid","year":"2026","journal-title":"Health Sci Rep"},{"issue":"19","key":"10.1016\/j.molmet.2026.102426_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/cells11193001","article-title":"Macrophages, chronic inflammation, and insulin resistance","volume":"11","author":"Li","year":"2022","journal-title":"Cells"},{"issue":"18","key":"10.1016\/j.molmet.2026.102426_bib14","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1080\/10408398.2017.1353479","article-title":"Nutrition, inflammation and liver-spleen axis","volume":"58","author":"Barrea","year":"2018","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"2","key":"10.1016\/j.molmet.2026.102426_bib15","first-page":"M57","article-title":"A new family of IKK-related kinases may function as I kappa B kinase kinases","volume":"1471","author":"Peters","year":"2001","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"10.1016\/j.molmet.2026.102426_bib16","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/intimm\/11.8.1357","article-title":"IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IkappaB kinases","volume":"11","author":"Shimada","year":"1999","journal-title":"Int Immunol"},{"issue":"11","key":"10.1016\/j.molmet.2026.102426_bib17","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1038\/s12276-021-00712-w","article-title":"Roles of IkappaB kinases and TANK-binding kinase 1 in hepatic lipid metabolism and nonalcoholic fatty liver disease","volume":"53","author":"Huh","year":"2021","journal-title":"Exp Mol Med"},{"issue":"17","key":"10.1016\/j.molmet.2026.102426_bib18","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.155552","article-title":"The TBK1\/IKKepsilon inhibitor amlexanox improves dyslipidemia and prevents atherosclerosis","volume":"7","author":"Zhao","year":"2022","journal-title":"JCI Insight"},{"issue":"19","key":"10.1016\/j.molmet.2026.102426_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251910721","article-title":"Knock-Out of IKKepsilon ameliorates atherosclerosis and fatty liver disease by alterations of lipid metabolism in the PCSK9 model in mice","volume":"25","author":"Weiss","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.molmet.2026.102426_bib20","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cell.2009.06.046","article-title":"The protein kinase IKKepsilon regulates energy balance in obese mice","volume":"138","author":"Chiang","year":"2009","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.molmet.2026.102426_bib21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nm.3082","article-title":"An inhibitor of the protein kinases TBK1 and IKK-varepsilon improves obesity-related metabolic dysfunctions in mice","volume":"19","author":"Reilly","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.molmet.2026.102426_bib22","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.01119","article-title":"Inflammation produces catecholamine resistance in obesity via activation of PDE3B by the protein kinases IKK{varepsilon} and TBK1","volume":"2","author":"Mowers","year":"2013","journal-title":"eLife"},{"key":"10.1016\/j.molmet.2026.102426_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s44355-024-00015-7","article-title":"Unlocking therapeutic potential of amlexanox in MASH with insights into bile acid metabolism and microbiome","volume":"2","author":"You","year":"2025","journal-title":"NPJ Gut Liver"},{"key":"10.1016\/j.molmet.2026.102426_bib24","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.neuropharm.2018.12.004","article-title":"Inhibition of the protein kinase IKKepsilon attenuates neuropathic pain in mice","volume":"146","author":"Moser","year":"2019","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.molmet.2026.102426_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13040504","article-title":"Effects of different storage conditions on lipid stability in mice tissue homogenates","volume":"13","author":"Dorochow","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.molmet.2026.102426_bib26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jmsacl.2023.02.002","article-title":"Pre-analytical sample handling standardization for reliable measurement of metabolites and lipids in LC-MS-based clinical research","volume":"28","author":"Sens","year":"2023","journal-title":"J Mass Spectrom Adv Clin Lab"},{"issue":"43","key":"10.1016\/j.molmet.2026.102426_bib27","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.molmet.2026.102426_bib28","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ng0506-500","article-title":"GenePattern 2.0","volume":"38","author":"Reich","year":"2006","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.molmet.2026.102426_bib29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/oxfordjournals.jbchem.a132724","article-title":"Effects of cholic acid, chenodeoxycholic acid, and their related bile acids on cholesterol, phospholipid, and bile acid levels in serum, liver, bile, and feces of rats","volume":"87","author":"Uchida","year":"1980","journal-title":"J Biochem"},{"issue":"3","key":"10.1016\/j.molmet.2026.102426_bib30","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1097-2765(00)00051-4","article-title":"A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis","volume":"6","author":"Goodwin","year":"2000","journal-title":"Mol Cell"},{"key":"10.1016\/j.molmet.2026.102426_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101795","article-title":"Not so fast: paradoxically increased variability in the glucose tolerance test due to food withdrawal in continuous glucose-monitored mice","volume":"77","author":"Rubio","year":"2023","journal-title":"Mol Metabol"},{"issue":"4","key":"10.1016\/j.molmet.2026.102426_bib32","first-page":"375","article-title":"Clinical Chemistry Reference Intervals for C57BL\/6J, C57BL\/6N, and C3HeB\/FeJ Mice (Mus musculus)","volume":"55","author":"Otto","year":"2016","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"10.1016\/j.molmet.2026.102426_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117010","article-title":"Amlexanox reversed non-alcoholic fatty liver disease through IKKepsilon inhibition of hepatic stellate cell","volume":"239","author":"He","year":"2019","journal-title":"Life Sci"},{"issue":"1","key":"10.1016\/j.molmet.2026.102426_bib34","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1038\/s41598-017-05040-6","article-title":"Metabolomic characteristics of cholesterol-induced Non-obese nonalcoholic fatty liver disease in mice","volume":"7","author":"Tu","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.molmet.2026.102426_bib35","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/01.ATV.0000201071.49029.17","article-title":"Diet and murine atherosclerosis","volume":"26","author":"Getz","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.molmet.2026.102426_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.813215","article-title":"Novel nongenetic murine model of hyperglycemia and hyperlipidemia-associated aggravated atherosclerosis","volume":"9","author":"Gaul","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"11","key":"10.1016\/j.molmet.2026.102426_bib37","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1161\/CIRCRESAHA.114.302937","article-title":"Induction of atherosclerosis in mice and hamsters without germline genetic engineering","volume":"114","author":"Bjorklund","year":"2014","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.molmet.2026.102426_bib38","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1172\/JCI114137","article-title":"Role of primary and secondary bile acids as feedback inhibitors of bile acid synthesis in the rat in vivo","volume":"84","author":"Stange","year":"1989","journal-title":"J Clin Investig"},{"issue":"11","key":"10.1016\/j.molmet.2026.102426_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166211","article-title":"Sex differences feed into nuclear receptor signaling along the digestive tract","volume":"1867","author":"Dean","year":"2021","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"4","key":"10.1016\/j.molmet.2026.102426_bib40","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.cmet.2014.08.002","article-title":"Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance","volume":"20","author":"Turpin","year":"2014","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.molmet.2026.102426_bib41","doi-asserted-by":"crossref","first-page":"50","DOI":"10.12997\/jla.2020.9.1.50","article-title":"Ceramides: nutrient signals that drive hepatosteatosis","volume":"9","author":"Summers","year":"2020","journal-title":"J Lipid Atheroscler"},{"issue":"7","key":"10.1016\/j.molmet.2026.102426_bib42","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.tips.2017.04.004","article-title":"Roles of diacylglycerols and ceramides in hepatic insulin resistance","volume":"38","author":"Petersen","year":"2017","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.molmet.2026.102426_bib43","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1055\/s-0039-1685524","article-title":"Lipid droplet formation and lipophagy in fatty liver disease","volume":"39","author":"Schulze","year":"2019","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.molmet.2026.102426_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2023.101238","article-title":"Lipidomics in pathogenesis, progression and treatment of nonalcoholic steatohepatitis (NASH): recent advances","volume":"91","author":"Musso","year":"2023","journal-title":"Prog Lipid Res"},{"issue":"1","key":"10.1016\/j.molmet.2026.102426_bib45","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s44324-024-00018-1","article-title":"Dysfunctional VLDL metabolism in MASLD","volume":"2","author":"Marigorta","year":"2024","journal-title":"NPJ Metab Health Dis"},{"issue":"11","key":"10.1016\/j.molmet.2026.102426_bib46","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000285","article-title":"Combined, elobixibat, and colestyramine reduced cholesterol toxicity in a mouse model of metabolic dysfunction-associated steatotic liver disease","volume":"7","author":"Iwaki","year":"2023","journal-title":"Hepatol Commun"},{"issue":"47","key":"10.1016\/j.molmet.2026.102426_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abq1984","article-title":"Macrophage acetyl-CoA carboxylase regulates acute inflammation through control of glucose and lipid metabolism","volume":"8","author":"Yeudall","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.molmet.2026.102426_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.970292","article-title":"The AMPK pathway in fatty liver disease","volume":"13","author":"Fang","year":"2022","journal-title":"Front Physiol"},{"issue":"3","key":"10.1016\/j.molmet.2026.102426_bib49","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/MOL.0b013e3282f9b54d","article-title":"Role of stearoyl-coenzyme A desaturase in regulating lipid metabolism","volume":"19","author":"Flowers","year":"2008","journal-title":"Curr Opin Lipidol"},{"issue":"1","key":"10.1016\/j.molmet.2026.102426_bib50","doi-asserted-by":"crossref","first-page":"E28","DOI":"10.1152\/ajpendo.90897.2008","article-title":"Biochemical and physiological function of stearoyl-CoA desaturase","volume":"297","author":"Paton","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.molmet.2026.102426_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115586","article-title":"SCD1 is the critical signaling hub to mediate metabolic diseases: mechanism and the development of its inhibitors","volume":"170","author":"Sun","year":"2024","journal-title":"Biomed Pharmacother"},{"issue":"17","key":"10.1016\/j.molmet.2026.102426_bib52","doi-asserted-by":"crossref","first-page":"11482","DOI":"10.1073\/pnas.132384699","article-title":"Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity","volume":"99","author":"Ntambi","year":"2002","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877826001109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877826001109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:03:43Z","timestamp":1790636623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877826001109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":52,"alternative-id":["S2212877826001109"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2026.102426","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex-specific differences of amlexanox in a mouse model for atherosclerosis and MASLD","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2026.102426","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"102426"}}